Kempharm

Develops prodrugs using Ligand Activated Therapy (LAT) technology platform improving efficacy of already approved drugs

placeCelebration, Florida, United States calendar_todayFounded 2006 groups36 employees language kempharm.com

Registered entities

Innovation

29 patent families (18 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 3,884 times.

YearFilings
20149
20157
20168
20178
201815
201912
202013
20218
20228
20234
20242
20252

Investor mix

1 investor on record.

Investor typeCountShare
Bank & private debt1100%
Coming soon